Andrew Arno insider trades: Oncocyte (OCX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC






Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | OCX | ↑ Buy | 12,500 | $2.11 | $26K | Direct | Dec 26, 2024 (0d) |
| Apr 11, 2024 | OCX | ↑ Buy | 33,898 | $2.95 | $100K | Direct | Apr 15, 2024 (4d) |
| Jan 5, 2024 | XXII | ↑ Buy | 100,000 | $0.17 | $17K | Direct | Jan 8, 2024 (3d) |
| Dec 23, 2022 | OCX | ↑ Buy | 250,000 | $0.35 | $88K | Direct | Dec 28, 2022 (5d) |
| Aug 22, 2022 | SMSI | ↑ Buy | 27,500 | $2.33 | $64K | Direct | Aug 22, 2022 (0d) |
| Aug 17, 2022 | OCX | ↑ Buy | 7,500 | $0.90 | $7K | Indirect | Aug 19, 2022 (2d) |
| Aug 17, 2022 | SMSI | ↑ Buy | 5,000 | $2.35 | $12K | By JBA Investment | Aug 18, 2022 (1d) |
| Aug 17, 2022 | SMSI | ↑ Buy | 5,000 | $2.35 | $12K | By spouse IRA | Aug 18, 2022 (1d) |
| Aug 17, 2022 | SMSI | ↑ Buy | 5,000 | $2.35 | $12K | By MJA Investment | Aug 18, 2022 (1d) |
| Aug 16, 2022 | OCX | ↑ Buy | 150,000 | $0.96 | $144K | Direct | Aug 17, 2022 (1d) |
| Sep 17, 2019 | OCX | ↑ Buy | 50,000 | $2.16 | $108K | Direct | Sep 18, 2019 (1d) |
| Jun 25, 2015 | AST | ↑ Buy | 5,000 | $4.32 | $22K | Direct | Jun 26, 2015 (1d) |
| Aug 25, 2011 | SMSI | ↑ Buy | 50,000 | $1.75 | $87K | Direct | Aug 25, 2011 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Andrew Arno's insider trades
Andrew Arno is a director at Oncocyte (OCX). Since Aug 25, 2011, Andrew has reported 13 open-market purchases worth $699K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (45 filings), shares withheld for taxes (1 filing), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OCX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.